DE68928968D1 - Metall-organische kobalt-verbindungen und deren verwendungen - Google Patents

Metall-organische kobalt-verbindungen und deren verwendungen

Info

Publication number
DE68928968D1
DE68928968D1 DE68928968T DE68928968T DE68928968D1 DE 68928968 D1 DE68928968 D1 DE 68928968D1 DE 68928968 T DE68928968 T DE 68928968T DE 68928968 T DE68928968 T DE 68928968T DE 68928968 D1 DE68928968 D1 DE 68928968D1
Authority
DE
Germany
Prior art keywords
group
treating
subject
different
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68928968T
Other languages
English (en)
Other versions
DE68928968T2 (de
Inventor
Zvi Dori
David Gershon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redox Pharmaceutical Corp
Original Assignee
Redox Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redox Pharmaceutical Corp filed Critical Redox Pharmaceutical Corp
Publication of DE68928968D1 publication Critical patent/DE68928968D1/de
Application granted granted Critical
Publication of DE68928968T2 publication Critical patent/DE68928968T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/06—Cobalt compounds
    • C07F15/065—Cobalt compounds without a metal-carbon linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemically Coating (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68928968T 1988-12-02 1989-12-04 Metall-organische kobalt-verbindungen und deren verwendungen Expired - Lifetime DE68928968T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/279,417 US5049557A (en) 1986-05-13 1988-12-02 Metallo-organic salt compounds and pharmaceutical uses thereof
PCT/US1989/005476 WO1990006119A1 (en) 1988-12-02 1989-12-04 Metallo-organic cobalt compounds and uses thereof

Publications (2)

Publication Number Publication Date
DE68928968D1 true DE68928968D1 (de) 1999-05-12
DE68928968T2 DE68928968T2 (de) 2000-01-05

Family

ID=23068878

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928968T Expired - Lifetime DE68928968T2 (de) 1988-12-02 1989-12-04 Metall-organische kobalt-verbindungen und deren verwendungen

Country Status (9)

Country Link
US (1) US5049557A (de)
EP (1) EP0481994B1 (de)
JP (1) JPH04507398A (de)
AT (1) ATE178608T1 (de)
AU (1) AU637340B2 (de)
CA (1) CA2004534C (de)
DE (1) DE68928968T2 (de)
IL (1) IL92512A (de)
WO (1) WO1990006119A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756491A (en) * 1986-05-13 1998-05-26 Chai-Tech Corporation Antiviral cobalt-organic compounds
US5106841A (en) * 1986-05-13 1992-04-21 Chai-Tech Corporation Antiviral compositions and method for their use
US5258403A (en) * 1986-05-13 1993-11-02 Chai-Tech Corporation Metallo-organic salt compounds and pharmaceutical uses thereof
AU5871494A (en) * 1992-12-15 1994-07-04 Redox Pharmaceutical Corporation Antiviral compositions and method for their use
US6008190A (en) * 1994-12-15 1999-12-28 California Institute Of Technology Cobalt Schiff base compounds
ATE489095T1 (de) * 1998-05-06 2010-12-15 Children S Hospital Res Foundation Verfahren zur hsv-prophylaxe
EP1085864B1 (de) * 1998-06-11 2005-08-31 Redox Pharmaceutical Corporation Verfahren zur prophylaxe von hiv und hpv
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US6756368B1 (en) 1999-07-16 2004-06-29 The Trustees Of Columbia University In The City Of New York Use of cobalt chelates for treating or preventing virus infection
AU6073000A (en) * 1999-07-16 2001-02-05 Trustees Of Columbia University In The City Of New York, The Use of cobalt chelates for treating or preventing virus infection
WO2001068088A1 (en) * 2000-03-10 2001-09-20 Children's Hospital Medical Center Method of chlamydia prophylaxis
WO2001077123A1 (en) * 2000-04-07 2001-10-18 California Institute Of Technology Towards increased shelf life for cobalt(iii) schiff base complexes
AU2004249292A1 (en) * 2003-06-20 2004-12-29 Redox Pharmaceutical Corporation Microbicidal, prophylactic and therapeutic effect of CTC-96 on papilloma viruses
JP4961700B2 (ja) 2005-09-08 2012-06-27 Ｊｎｃ株式会社 末端が水素であるナフタレン誘導体、この誘導体を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
WO2010111257A2 (en) * 2009-03-23 2010-09-30 Northwestern University Targeted schiff base complexes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3420865A (en) * 1966-05-12 1969-01-07 Colgate Palmolive Co Novel carbocyclic ferrocenes
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
CA1218600A (en) * 1982-12-06 1987-03-03 Gerald L. Maurer Methods and compositions for treating inflammation or arthritis
DE3404443A1 (de) * 1984-02-08 1985-08-08 Hartmut Prof. Dr. 1000 Berlin Köpf Metallicenium-salze und deren verwendung als cytostatica bei der krebsbekaempfung
US4514522A (en) * 1984-07-27 1985-04-30 University Patents, Inc. Oxygen sorbent
US4727068A (en) * 1985-10-23 1988-02-23 Johnson Matthey, Inc. Radiosensitization by cobalt and Fe(III) complexes
IL82376A (en) * 1986-05-13 1991-06-10 Chai Tech Corp Pharmaceutical composition for the treatment of inflammatory conditions
US4735634A (en) * 1986-08-28 1988-04-05 Air Products And Chemicals, Inc. Pillared cobalt complexes for oxygen separation
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
US4950790A (en) * 1988-11-14 1990-08-21 Air Products And Chemicals, Inc. Volatile fluorinated β-ketoimines and associated metal complexes
CA2004639A1 (en) * 1988-12-12 1990-06-12 John A. T. Norman Fluorinated beta-ketoimines and beta-ketoiminato metal complexes

Also Published As

Publication number Publication date
CA2004534A1 (en) 1990-06-02
EP0481994A4 (en) 1993-03-03
IL92512A (en) 1998-12-06
US5049557A (en) 1991-09-17
IL92512A0 (en) 1990-08-31
AU4748390A (en) 1990-06-26
JPH04507398A (ja) 1992-12-24
DE68928968T2 (de) 2000-01-05
EP0481994A1 (de) 1992-04-29
EP0481994B1 (de) 1999-04-07
WO1990006119A1 (en) 1990-06-14
CA2004534C (en) 1995-12-26
ATE178608T1 (de) 1999-04-15
AU637340B2 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
DE68928968D1 (de) Metall-organische kobalt-verbindungen und deren verwendungen
IT1178154B (it) Impiego in terapia di composti di trasferimento di metilolo, relative composizioni farmaceutiche e procedimento per preparare queste
CA2045077A1 (en) Anti-epileptics
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
DE69330282D1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
IL97729A0 (en) Antiviral compositions and method for their use
DE69312567D1 (de) 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel
MY115805A (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
ES8200680A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
IE39679L (en) Methods and compositions for killing parasites of warm¹blooded animals
ES8300116A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
IL70082A (en) Pharmaceutical compositions comprising 1-aroyl-5-oxo-2-pyrrolidinopropanoic acids and salts and esters thereof,certain such compounds and their preparation
ES535903A0 (es) Procedimiento de preparacion de derivados de nitrosoureas
DE3175939D1 (en) Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1045657A (en) Dialkylaminoalkyl estrone oxime derivatives
RU98122542A (ru) Способ лечения астмы, применение замещенного азаспирана при лечении астмы
JPS6452720A (en) Nootropic

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN